Light Sciences Oncology Overview
- Year Founded
-
1994
- Status
-
Out of Business
- Employees
-
17
- Latest Deal Type
-
Out of Business
Light Sciences Oncology General Information
Description
Developer of a water-soluble drug designed to treat solid tumors. The company's Talaporfin Sodium drug is a water-soluble drug targeted by a small, single-use and disposable drug activator, enabling patients to get repeatable and non-invasive treatment treatments.
Contact Information
Website
www.lsoncology.comCorporate Office
- 12600 South East 38th Street
- Suite 111
- Bellevue, WA 98006
- United States
Corporate Office
- 12600 South East 38th Street
- Suite 111
- Bellevue, WA 98006
- United States
Light Sciences Oncology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Out of Business | 01-Jul-2019 | Completed | Out of Business | |||
| 9. Later Stage VC | 10-Jan-2019 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 20-Dec-2013 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 23-Jan-2012 | Completed | Generating Revenue | |||
| 6. Grant | 02-Nov-2010 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 16-Jul-2008 | Completed | Generating Revenue | |||
| 4. IPO | 07-Feb-2008 | Cancelled | Generating Revenue | |||
| 3. Debt - General | 31-Dec-2007 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series B) | 11-Jul-2007 | $30M | $100M | Completed | Generating Revenue | |
| 1. Later Stage VC (Series A) | 14-Dec-2005 | $70M | $70M | Completed | Generating Revenue |
Light Sciences Oncology Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 13,429,989 | $0.4 | $5 | $5 | $8 | 17.52% |
Light Sciences Oncology Patents
Light Sciences Oncology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2011020064-A2 | Low-profile intraluminal light delivery system and methods of using the same | Inactive | 14-Aug-2009 | ||
| WO-2011020064-A3 | Low-profile intraluminal light delivery system and methods of using the same | Inactive | 14-Aug-2009 | ||
| US-20110008372-A1 | Enhancement of light activated drug therapy through combination with other therapeutic agents | Inactive | 08-Jul-2009 | ||
| US-20100036311-A1 | Enhancement of light activated therapy by immune augmentation using anti-ctla-4 antibody | Active | 06-Aug-2008 | ||
| US-20110236402-A1 | Enhancement of light activated therapy by immune augmentation using anti-ctla-4 antibody | Active | 06-Aug-2008 | A61K41/0038 |
Light Sciences Oncology Signals
Light Sciences Oncology Acquisitions (2)
Light Sciences Oncology’s most recent deal was a Merger/Acquisition with Life Science. The deal was made on 29-Dec-2006.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Life Science | 29-Dec-2006 | Merger/Acquisition | Therapeutic Devices | ||
| Light Sciences | 29-Dec-2006 | Merger/Acquisition | Drug Discovery |
Light Sciences Oncology FAQs
-
When was Light Sciences Oncology founded?
Light Sciences Oncology was founded in 1994.
-
Where is Light Sciences Oncology headquartered?
Light Sciences Oncology is headquartered in Bellevue, WA.
-
What is the size of Light Sciences Oncology?
Light Sciences Oncology has 17 total employees.
-
What industry is Light Sciences Oncology in?
Light Sciences Oncology’s primary industry is Drug Discovery.
-
Is Light Sciences Oncology a private or public company?
Light Sciences Oncology is a Private company.
-
What is Light Sciences Oncology’s current revenue?
The current revenue for Light Sciences Oncology is .
-
How much funding has Light Sciences Oncology raised over time?
Light Sciences Oncology has raised $195M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process